Silver Coast Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,564
Closed -$429K 125
2026
Q1
$429K Sell
3,564
-206
-5% -$23.8K 0.14% 68
2025
Q4
$397K Buy
3,770
+7
+0.2% +$657 0.14% 67
2025
Q3
$316K Sell
3,763
-574
-13% -$47.3K 0.11% 83
2025
Q2
$343K Buy
4,337
+103
+2% +$8.19K 0.12% 77
2025
Q1
$380K Buy
4,234
+1,274
+43% +$119K 0.14% 60
2024
Q4
$294K Buy
2,960
+433
+17% +$44.6K 0.11% 72
2024
Q3
$287K Buy
2,527
+129
+5% +$15.3K 0.11% 76
2024
Q2
$297K Buy
2,398
+164
+7% +$21.1K 0.12% 65
2024
Q1
$295K Sell
2,234
-135
-6% -$16.6K 0.12% 64
2023
Q4
$258K Buy
+2,369
New +$246K 0.12% 59

Other funds holding MRK

Silver Coast Investments's MRK Position: Q2 2026 in Review

Silver Coast Investments sold out of Merck (MRK) in Q2 2026, closing a stake of 3,564 shares — an estimated $429K sold.

Silver Coast Investments first reported a position in MRK in Q4 2023 and held it in 10 quarters. The position peaked at $429K in Q1 2026. 2,318 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Silver Coast Investments reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Silver Coast Investments sold 3,564 Merck shares in Q2 2026, an estimated $429K.
  • Silver Coast Investments first reported a position in Merck in Q4 2023 and held it in 10 quarters.
  • Silver Coast Investments's Merck position peaked at $429K in Q1 2026.
  • 2,318 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Silver Coast Investments's 13F filing for Q2 2026, filed 24 Jul 2026.